Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
株式のランク #26586
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
株価
$0.36696844
時価総額
$38.56M
変化(1日)
-13.79%
変化(1年)
45.45%
CA
取引 BioMark Diagnostics Inc. (BUX)

カテゴリー

BioMark Diagnostics Inc.(BUX)の配当利回りの履歴
BioMark Diagnostics Inc.(銘柄コード: BUX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
BioMark Diagnostics Inc.(BUX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)